We welcome organizations, institutions, vendors and industry involvement.
Contact us to add your logo or to become a Partner or Patron.
2023 Lead Partner
CSID is a disorder that reduces the effectiveness of enzymes that digest carbohydrates (sugar and starch). Congenital Sucrase-Isomaltase Deficiency, also known as Genetic Sucrase-Isomaltase Deficiency (GSID), is an inherited disorder that causes these digestive enzymes either to be missing or to not work as well. Sucraid® is the only FDA-approved enzyme replacement therapy for the treatment of CSID.
2023 Fellow Partners
Friends of World IBS Day
Australia
Austria
Canada
Denmark
France
Germany
India
Ireland
Italy
Japan
Malaysia
Pantai Hospital Ayer Keroh (Malaysia)
Netherlands
Norway
Spain
United Kingdom
United States
UT Health Austin (US)